Linaclotide

Trade Name: 
Constella
Manufacturer/Distributor: 
Forest Laboratories Canada
www.frx.ca
1-855-894-1747
Classification: 
Guanylate cyclase-C agonist
ATC Class: 
A06AX04 - linaclotide
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2013/12/02
Date Marketed in Canada (yyyy/mm/dd): 
2014/05
Presentation: 
Capsule: 145 mcg. DIN: 02417162
Capsule: 290 mcg. DIN: 02417170
Comments: 
Linaclotide is indicated for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults. The drugs acts locally on the luminal surface of the intestinal epithelium resulting in increased intestinal fluid and accelerated transit.